Arcoma

Arcoma CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Arcoma (ARCOMA.ST) as of Nov 1, 2026 is 30.04 %. In the previous year, CapEx to Operating Cash Flow Ratio was 35.98 % — a change of -16.51% (lower).

CapEx/OCF

30.04 %

YoY

-16.51%

Last updated:

CapEx to Operating Cash Flow Ratio of Arcoma is 2025 30.04 % . CapEx to Operating Cash Flow Ratio of Arcoma was 2024 35.98 % . It decreases by -16.51% lower compared to the previous year.

The Arcoma CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
2,035.56 SEK
Jan 1, 2019
100.25 SEK
Jan 1, 2020
170.92 SEK
Jan 1, 2021
-216.77 SEK
Jan 1, 2022
-2,329.05 SEK
Jan 1, 2023
13.32 SEK
Jan 1, 2024
35.98 SEK
Jan 1, 2025
30.04 SEK
The Arcoma CapEx/OCF history
YEARCapEx/OCFYoY
30.04 %-16.51%
35.98 %+170.05%
13.32 %-100.57%
-2,329.05 %+974.43%
-216.77 %-226.83%
170.92 %+70.49%
100.25 %-95.07%
2,035.56 %-5,922.41%
-34.96 %+86.22%
-18.77 %-81.25%
-100.14 %-84.80%
-658.94 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

CapEx to Operating Cash Flow Ratio of Arcoma is 30.04 % in 2025.

CapEx to Operating Cash Flow Ratio of Arcoma changed from 35.98 % to 30.04 %, representing a -16.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Arcoma since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Arcoma with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Arcoma

All Key Metrics — Arcoma